mortality/aging
• median survival is 94 days compared to 142 days in control ApcMin heterozygotes
|
neoplasm
• mice develop tumors in the small intestine with no difference in number, distribution, size and histology from tumors in single ApcMin heterozygotes
|
• mean number of colonic tumors is 11.9 compared to 3.1 in control ApcMin heterozygotes and mice show an increase in mean tumor multiplicity in both the proximal and distal colon
• by 10 weeks of age, mice show more tumors in the colon than in single ApcMin heterozygotes, with 29% of tumors being adenocarcinoma
• no metastases to lymph nodes, liver or lungs are seen
|
• 65% of colon tumors are adenomas
|
• 35% of colon tumors are adenocarcinomas
• 97% of carcinomas are located in the distal colon
|
digestive/alimentary system
• vast majority of polyps localize to the small intestine
|
• mice develop tumors in the small intestine with no difference in number, distribution, size and histology from tumors in single ApcMin heterozygotes
|
• mean number of colonic tumors is 11.9 compared to 3.1 in control ApcMin heterozygotes and mice show an increase in mean tumor multiplicity in both the proximal and distal colon
• by 10 weeks of age, mice show more tumors in the colon than in single ApcMin heterozygotes, with 29% of tumors being adenocarcinoma
• no metastases to lymph nodes, liver or lungs are seen
|
• 65% of colon tumors are adenomas
|
• 35% of colon tumors are adenocarcinomas
• 97% of carcinomas are located in the distal colon
|
Mouse Models of Human Disease |
DO ID | OMIM ID(s) | Ref(s) | |
colorectal cancer | DOID:9256 |
OMIM:114500 |
J:216704 |